Plains GP (NYSE:PAGP – Free Report) had its price objective increased by Truist Financial from $23.00 to $25.00 in a research note issued to investors on Wednesday morning,Benzinga reports. The firm currently has a buy rating on the pipeline company’s stock.
Other research analysts also recently issued reports about the company. Zacks Research downgraded Plains GP from a “hold” rating to a “strong sell” rating in a report on Monday, June 22nd. Citigroup upped their target price on Plains GP from $20.00 to $23.00 and gave the stock a “neutral” rating in a report on Thursday, May 14th. US Capital Advisors downgraded Plains GP from a “strong-buy” rating to a “moderate buy” rating in a research report on Friday, May 29th. Barclays raised their price target on Plains GP from $18.00 to $21.00 and gave the company an “underweight” rating in a research note on Friday, April 10th. Finally, Mizuho upped their price objective on shares of Plains GP from $25.00 to $27.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $23.36.
Check Out Our Latest Analysis on Plains GP
Plains GP Stock Performance
Plains GP Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 31st will be issued a dividend of $0.4175 per share. The ex-dividend date is Friday, July 31st. This represents a $1.67 dividend on an annualized basis and a yield of 6.5%. Plains GP’s dividend payout ratio is currently 172.16%.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the stock. Royal Bank of Canada lifted its stake in shares of Plains GP by 6.1% during the 1st quarter. Royal Bank of Canada now owns 468,314 shares of the pipeline company’s stock worth $10,003,000 after purchasing an additional 26,952 shares during the last quarter. Natixis bought a new position in Plains GP in the second quarter worth about $1,029,000. Qube Research & Technologies Ltd raised its holdings in Plains GP by 7.6% in the second quarter. Qube Research & Technologies Ltd now owns 990,557 shares of the pipeline company’s stock worth $19,247,000 after purchasing an additional 69,970 shares in the last quarter. NewEdge Advisors LLC raised its holdings in Plains GP by 5.9% in the second quarter. NewEdge Advisors LLC now owns 84,136 shares of the pipeline company’s stock worth $1,635,000 after purchasing an additional 4,692 shares in the last quarter. Finally, Diversify Advisory Services LLC purchased a new stake in shares of Plains GP during the second quarter valued at about $279,000. 88.30% of the stock is currently owned by hedge funds and other institutional investors.
Plains GP Company Profile
Plains GP Holdings, L.P. (NYSE: PAGP) serves as the general partner of Plains All American Pipeline, L.P., one of North America’s leading energy infrastructure companies. Through its ownership of a 2% general partner interest and incentive distribution rights (IDRs), Plains GP Holdings participates in the governance and cash distribution structure of a diversified portfolio of crude oil and natural gas liquids gathering, transportation, storage, and terminaling assets.
The company’s primary business activities include overseeing the strategic direction and capital allocation decisions for its affiliated midstream operations.
Featured Articles
- Five stocks we like better than Plains GP
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for Plains GP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plains GP and related companies with MarketBeat.com's FREE daily email newsletter.
